The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
If you aren't terrified by this heatwave, you should be
2
Woman with Alzheimer's starts conversing again after taking psilocybin
3
The race to understand how and when Thwaites glacier will collapse
4
Where, when and how to watch the 2026 solar eclipse
5
Europe’s heatwave is the hottest and most humid ever
6
Faecal transplant makes the brains of old mice act young again
7
We’ve uncovered a master gene that switches on human development
8
How menopause radically changes the brain – and what happens after
9
Our verdict on The Selfish Gene: An unpopular piece of popular science
10
Lost books by ancient philosophers recovered from 'unreadable' scrolls
